Francine Yellson

Bachelor of Medicine and Bachelor of Science,  Massachusetts General Hospital 

Location: Africa

Consulting Services

Admin and Customer Support Grant Submission Hospital-Pharmacy-Insurance Data Science-Bioinformatics

Areas Of Interest

Phobias, School Component 5, Complement Corn Oil CD20 Antibody, Rituximab Arachnid Vectors Religious Mission Antigen, CD151 True Hermaphroditisms, Familial Relative Biologic Effectiveness Pharynx Actinic Dermatitides, Chronic Bridged Compounds Synaptic Pruning Adaption, Salt Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha Digoxin Hantavirus Pulmonary Syndromes Stichoneuron Ephemera Receptor, Pulmonary Stretch Medical Mistake ATP Synthase, Mitochondrial Familial Dementias Bowens Disease Venus Flytrap Florida Lancelets Fructose Biphosphate Aldolase Glucan (BO) Calelectrin 67 kDa Succinate, Ammonium Noscapine Hydrochloride PCN

Professional Narrative

Dr. Francine Yellson was born in DuBois, Pennsylvania and is a graduate of Villanova University. He obtained his medical degree at Thomas Jefferson University in Philadelphia. His residency was at Thomas Jefferson and its affiliated Wills Eye Hospital, and he completed his training with fellowships at the University of Connecticut incataract andcorneal surgery.

Dr. Yellson has thirty years’ experience in ophthalmic surgery,withspecialinterestin cataract surgery,corneal transplantation,andlaserrefractiveprocedures.Heisa founding member of Precision LASIK Group, Chief of Ophthalmology at The Hospital ofCentral Connecticut,andco-medical director of the Connecticut eye bank.


Employment

Medical Writer, Mayo Clinic 2011
Assistant Professor, Amgen 2008

Education

Doctor of osteopathic medicine, Weill Medical College 2003
Director Medicine, Perelman School of Medicine 1998

Referees


Publications

Hou X, Zaks T, Langer R, Dong Y. Lipid nanoparticles for mRNA delivery. Nat Rev Mater. 2021;6(12):1078-1094. doi: 10.1038/s41578-021-00358-0. Epub 2021 Aug 10. PMID: 34394960; PMCID: PMC8353930.

Tang Z, Kong N, Zhang X, Liu Y, Hu P, Mou S, Liljeström P, Shi J, Tan W, Kim JS, Cao Y, Langer R, Leong KW, Farokhzad OC, Tao W. A materials-science perspective on tackling COVID-19. Nat Rev Mater. 2020;5(11):847-860. doi: 10.1038/s41578-020-00247-y. Epub 2020 Oct 14. PMID: 33078077; PMCID: PMC7556605.

Oberli MA, Reichmuth AM, Dorkin JR, Mitchell MJ, Fenton OS, Jaklenec A, Anderson DG, Langer R, Blankschtein D. Lipid Nanoparticle Assisted mRNA Delivery for Potent Cancer Immunotherapy. Nano Lett. 2017 Mar 8;17(3):1326-1335. doi: 10.1021/acs.nanolett.6b03329. Epub 2016 Dec 5. PMID: 28273716; PMCID: PMC5523404.

Roberts TC, Langer R, Wood MJA. Advances in oligonucleotide drug delivery. Nat Rev Drug Discov. 2020 Oct;19(10):673-694. doi: 10.1038/s41573-020-0075-7. Epub 2020 Aug 11. PMID: 32782413; PMCID: PMC7419031.


Grants,Awards and Certifications

Grants :

No Grants Mentioned !!

Awards & Prizes :


Languages

Language Proficiency :

Translation Services :